Sharma, Ashish http://orcid.org/0000-0002-8550-9791
Parachuri, Nikulaa
Kumar, Nilesh http://orcid.org/0000-0002-7439-2081
Bandello, Francesco
Kuppermann, Baruch D.
Article History
Received: 15 June 2022
Revised: 30 June 2022
Accepted: 4 July 2022
First Online: 14 July 2022
Competing interests
: AS: CONSULTANT: for Novartis, Allergan, Bayer and Intas. FB: CONSULTANT: Allergan, Bayer, Boehringer- Ingelheim, FidiaSooft, Hofmann La Roche, Novartis, NTC Pharma, Sifi, Thrombogenics, Zeiss. BDK: CLINICAL RESEARCH: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; CONSULTANT: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, Theravance Biopharma. NK: None. NP: None.